Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Taylor

Showing results (91-100 of 999) with videos related to

Pageof 100
Sort By:
CNS Drugs|February 28, 2022
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?Sofia Brissos, David Taylor
Journal of the Mechanical Behavior of Biomedical Materials|July 25, 2009
Special issue on nanoindentation of biological materialsMichelle Oyen, David Taylor
The Lancet. Psychiatry|October 22, 2019
How do we determine whether antidepressants are useful or not?Mark Horowitz, David Taylor
Journal of the Mechanical Behavior of Biomedical Materials|December 25, 2024
Analysis of cutting forces and microdamage during indentation cutting of boneGer Reilly, David Taylor
The International Journal of Psycho-Analysis|April 4, 2006
Continuity and change in the post-Kleinian evolution in London: clinical work of John Steiner, Ronald Britton and Michael Feldman (1988-2004)Ron Spielman, David Taylor
Sociology of Health & Illness|February 9, 2007
Chronic illness, expert patients and care transitionDavid Taylor, Michael Bury
Journal of the Mechanical Behavior of Biomedical Materials|December 21, 2020
Erosion of soft tissue by polypropylene mesh productsAmanda Schmidt, David Taylor
International Clinical Psychopharmacology|January 15, 2014
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalizationDavid Taylor, Olubanke Olofinjana
Drugs|November 1, 2008
Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerabilityDelia Bishara, David Taylor
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depressionBrian Leonard, David Taylor
Pageof 100

Showing results (91-100 of 999) with videos related to

Sort By:
Pageof 100
CNS Drugs|February 28, 2022
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?Sofia Brissos, David Taylor
Journal of the Mechanical Behavior of Biomedical Materials|July 25, 2009
Special issue on nanoindentation of biological materialsMichelle Oyen, David Taylor
The Lancet. Psychiatry|October 22, 2019
How do we determine whether antidepressants are useful or not?Mark Horowitz, David Taylor
Journal of the Mechanical Behavior of Biomedical Materials|December 25, 2024
Analysis of cutting forces and microdamage during indentation cutting of boneGer Reilly, David Taylor
The International Journal of Psycho-Analysis|April 4, 2006
Continuity and change in the post-Kleinian evolution in London: clinical work of John Steiner, Ronald Britton and Michael Feldman (1988-2004)Ron Spielman, David Taylor
Sociology of Health & Illness|February 9, 2007
Chronic illness, expert patients and care transitionDavid Taylor, Michael Bury
Journal of the Mechanical Behavior of Biomedical Materials|December 21, 2020
Erosion of soft tissue by polypropylene mesh productsAmanda Schmidt, David Taylor
International Clinical Psychopharmacology|January 15, 2014
Long-acting paliperidone palmitate - interim results of an observational study of its effect on hospitalizationDavid Taylor, Olubanke Olofinjana
Drugs|November 1, 2008
Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerabilityDelia Bishara, David Taylor
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depressionBrian Leonard, David Taylor
Pageof 100